Clare R. Ozawa, Ph.D. - Publications

Affiliations: 
2002 Stanford University, Palo Alto, CA 
Area:
Neuroscience Biology, Cell Biology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 von Degenfeld G, Banfi A, Springer ML, Wagner RA, Jacobi J, Ozawa CR, Merchant MJ, Cooke JP, Blau HM. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2657-9. PMID 17095533 DOI: 10.1096/Fj.06-6568Fje  0.571
2004 Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. The Journal of Clinical Investigation. 113: 516-27. PMID 14966561 DOI: 10.1172/Jci18420  0.589
2003 Springer ML, Ozawa CR, Banfi A, Kraft PE, Ip TK, Brazelton TR, Blau HM. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 441-9. PMID 12727106 DOI: 10.1016/S1525-0016(03)00010-8  0.494
2002 Springer ML, Ozawa CR, Blau HM. Transient production of alpha-smooth muscle actin by skeletal myoblasts during differentiation in culture and following intramuscular implantation. Cell Motility and the Cytoskeleton. 51: 177-86. PMID 11977092 DOI: 10.1002/Cm.10022  0.575
2000 Tsai DJ, Ho JJ, Ozawa CR, Sapolsky RM. Long-term expression driven by herpes simplex virus type-1 amplicons may fail due to eventual degradation or extrusion of introduced transgenes. Experimental Neurology. 165: 58-65. PMID 10964485 DOI: 10.1006/Exnr.2000.7454  0.312
2000 Ozawa CR, Springer ML, Blau HM. A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors. Annual Review of Pharmacology and Toxicology. 40: 295-317. PMID 10836138 DOI: 10.1146/Annurev.Pharmtox.40.1.295  0.501
Show low-probability matches.